supersizeme said:Best wishes to you, natty.
Fonz - I hope one day you can look back at that one time you advised a guy about to go through chemotherapy to use steroids so that he won't lose muscle and think to yourself, "Well that was pretty fuckin' stupid of me."
The short-sightedness of some people here just amazes me.
Ok. I will proceed to cut your post to pieces as I'm sick of chat board ignorants.
1: J Clin Endocrinol Metab 2001 Nov;86(11):5108-17 Related Articles, Links
Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases.
Basaria S, Wahlstrom JT, Dobs AS.
The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
The purpose of this study was to review the preclinical and clinical literature relevant to the efficacy and safety of anabolic androgen steroid therapy for palliative treatment of severe weight loss associated with chronic diseases. Data sources were published literature identified from the Medline database from January 1966 to December 2000, bibliographic references, and textbooks. Reports from preclinical and clinical trials were selected. Study designs and results were extracted from trial reports. Statistical evaluation or meta-analysis of combined results was not attempted. Androgenic anabolic steroids (AAS) are widely prescribed for the treatment of male hypogonadism;
Here:
however, they may play a significant role in the treatment of other conditions as well, such as cachexia associated with human immunodeficiency virus, cancer, burns, renal and hepatic failure, and anemia associated with LUKEMIA or kidney failure. A review of the anabolic effects of androgens and their efficacy in the treatment of these conditions is provided. In addition, the numerous and sometimes serious side effects that have been known to occur with androgen use are reviewed. Although the threat of various side effects is present, AAS therapy appears to have a favorable anabolic effect on patients with chronic diseases and muscle catabolism.
Here:
We recommend that AAS can be used for the treatment of patients with acquired immunodeficiency syndrome wasting and in severely catabolic patients with severe burns. Preliminary data in renal failure-associated wasting are also positive. Advantages and disadvantages should be weighed carefully when comparing AAS therapy to other weight-gaining measures. Although a conservative approach to the use of AAS in patients with chronic diseases is still recommended, the utility of AAS therapy in the attenuation of severe weight loss associated with disease states such as cancer, postoperative recovery, and wasting due to pulmonary and hepatic disease should be more thoroughly investigated.
Publication Types:
Review
Review, Academic
PMID: 11701661 [PubMed - indexed for MEDLINE]
--------------------------------------------------------------------------------
and:
1: Nouv Presse Med 1976 May 15;5(20):1289-93 Related Articles, Links
[Trial of androgen therapy in the treatment of non-lymphoblastic acute leukemia. First results]
[Article in French]
Hollard D, Sotto JJ, Bachelot C, Michallet M, Ribaud P, Schaerer R, Waguet JC.
Addition of a daily dose of androgen in the form of 0.15 mg/kg of Stanzolol, given without interruption, gave an average survival of more than 4 years in patients suffering from granulocyte series acute leukaemias after complete remission was obtained. The simplicity of this treatment is apparent only from the appearance of marked manifestations of androgen impregnation in women from the 8th month of treatment onwards. These results, superior to those obtained up to the present time in the survival of myeloid leukaemias (non-lymphoblastic) were also better in terms of the stability and X "quality" of the remission in comparison to those obtained in acute lymphoblastic leukaemias. Confirmation of these results by controlled clinical trial will open up interesting perspectives, along side immunotherapy which remains of unproven effectiveness in myeloid leukaemias. The effectiveness of androgen stimulation of haematopoiesis as a stabilising factor of complete remissions in acute leukaemias has, in addition, interesting implications with regard to the theory of the leukaemic process.
PMID: 1064847 [PubMed - indexed for MEDLINE]
and:
The kicker:
1: Nouv Rev Fr Hematol 1975 Jan-Feb;15(1):57-72 Related Articles, Links
[Androgens and prolonged complete remissions in acute non lymphoblastic leukemias. Results of a systematic treatment with stanozolol associated with chemotherapy (author's transl)]
[Article in French]
Sotto JJ, Hollard D, Schaerer R, Bensa JC, Seigneurin D.
An androgen (stanozolol: 0,15 mg/kg/d) was systematically associated to the treatment of acute non lymphoblastic leukemias, since the beginning of induction therapy (vincristin, daunorubicin, prednisone) and throughout the maintenance period (6-mercaptopurine and methotrexate). Thirty-six patients less than 60 years old (median age: 44 years) presenting with acute non-lymphoblastic leukemia were entered to the study.
Here:
Sixteen achieved complete remission (C.R.), i.e. 44% of the whole and 53% of treated patients. Out of 16 patients with complete remission, 4 relapsed during the observation period which lasted 4-1/2 years. The stability of the hematologic equilibrium in patients in C.R. is the main finding of the present study. The actuarial curve of the duration of the first complete remission reaches a "plateau"; after the 8th month only one relapse was observed in 9 patients. The rate of C.R. at 2 years is 76 +/- 23%. As compared to the results from other schedules of treatment, this rate appears significantly better, specially in the case of immunotherapy (p less than 0,001). A prospective randomized study is now suggested as to confirm this result; its therapeutic and theoretical basis and perspectives are discussed.
PMID: 126425 [PubMed - indexed for MEDLINE]
Gee whiz, seems that chemo+AAS is beneficiary, and can actually help people enter remisssion.
After so long on this site, you still know squat.
Great.
Instead of saying your condolences, RESEARCH STUFF for him. We're supposed to be IRON BROTHERS. You should do all you can for him. Also, a doctor can only do so much and follows very, very old guidelines.
What will NAtty do when he's 140lbs after chemo?
Wish he had used SAFE AAS like oxandrolone abd Deca.
Just ask Daeo. He contributed much of his recovery from chemo to his use of AAS in low doses.
It still amazes me how lazy some people are.
Fonz